Effects of Ranibizumab, Bevacizumab, and Aflibercept on Senescent Retinal Pigment Epithelial Cells.

Korean journal of ophthalmology : KJO（2018）

引用 0|浏览5

暂无评分

摘要

Clinical dosages of ranibizumab, bevacizumab, or aflibercept do not induce significant cytotoxicity in senescent RPE cells.

查看译文

关键词

Aflibercept,Aging,Bevacizumab,Ranibizumab,Retinal pigment epithelial cells

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要